This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Innovations of Katie-Rose Skelly
Introduction
Katie-Rose Skelly is an accomplished inventor based in Salt Lake City, UT. She has made significant contributions to the field of pharmaceuticals and biotechnology. With a total of two patents to her name, her work focuses on innovative methods for evaluating query perturbations in cell-based assays.
Latest Patents
Katie-Rose Skelly's latest patents include systems and methods for evaluating query perturbations. These methods provide a framework for assessing a query perturbation in a cell-based assay representing a test state. The process involves obtaining control data points that represent measurements of different features across control cell aliquots. Additionally, test data points are gathered, which represent measurements of different features across test cell aliquots. A composite test vector is then computed between measures of central tendency across the control and test data points. Furthermore, query perturbation data points are obtained, leading to the computation of a composite query perturbation vector that reflects the relationship between control data points and the plurality of query perturbation data points.
Career Highlights
Katie-Rose Skelly is currently employed at Recursion Pharmaceuticals, Inc., where she continues to innovate in her field. Her work is instrumental in advancing the understanding of cell-based assays and their applications in pharmaceuticals.
Collaborations
Some of her notable coworkers include Mason L Victors and Berton Allen Earnshaw. Their collaborative efforts contribute to the innovative environment at Recursion Pharmaceuticals.
Conclusion
Katie-Rose Skelly exemplifies the spirit of innovation in the pharmaceutical industry through her patents and contributions. Her work continues to pave the way for advancements in cell-based assays and query perturbation evaluations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile